Browsing publications by Dr Gareth Veal

Newcastle AuthorsTitleYear
Dr Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.		Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
Christopher Hill
Dr David Jamieson
Huw Thomas
Dr Colin Brown
Professor Alan Boddy
et al.		Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo2013
Dr Gareth Veal
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial2012
Dr Gareth Veal
Professor Alan Boddy
Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoring2012
Dr Gareth Veal
Professor Alan Boddy
Chemotherapy in newborns and preterm babies2012
Professor Isabella Orienti
Dr Gareth Veal
Novel micelles based on amphiphilic branched PEG as carriers for fenretinide2012
Dr Caroline Bridgens
Dr Gareth Veal
Dr Christopher Redfern
Dr Jane Armstrong
Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold2012
Professor Ann Daly
Dr Gareth Veal
Dr David Jamieson
Dr Sally Coulthard
Pharmacogenomics research at Newcastle University2012
Dr Caroline Bridgens
Dr Gareth Veal
Dr Christopher Redfern
Dr Jane Armstrong
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates2012
Dr Jane Armstrong
Shaun Martin
Nicola Illingworth
Dr David Jamieson
Dr Penny Lovat
et al.		The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide2012
1234567